Skip to main content
. 2019 Mar 5;16:10. doi: 10.1186/s12014-019-9230-8

Fig. 4.

Fig. 4

Analysis of biomarkers in sera from UM patients and healthy controls. ag expression of OPN, MIA, CEACAM-1, MIC-1, SPON1, POSTN, and HSP27 in UM patients who either remained disease-free (DF) for at least 5 years after treatment for primary UM, patients who died with clinically overt metastases from UM, ptients in whom relavant clinicopathologic information was not available (NA), and healthy controls. Bars indicate median value